John Rubenstein is Nina Ireland distinguished professor in child psychiatry at the University of California, San Francisco, Weill Institute for Neurosciences.
John Rubenstein
Professor
University of California, San Francisco
From this contributor
Understanding contradictory connectivity reports in autism
Studies at the level of neural circuits are needed to better understand the importance of both increased and decreased connectivity between different regions in the autism brain, say John Rubenstein and Vikaas Sohal.
Understanding contradictory connectivity reports in autism
By
John Rubenstein, Vikaas Sohal
10 December 2013 | 5 min read
Explore more from The Transmitter
NIH neurodevelopmental assessment system now available as iPad app
Here is a roundup of autism-related news and research spotted around the web for the week of 24 March.
NIH neurodevelopmental assessment system now available as iPad app
Here is a roundup of autism-related news and research spotted around the web for the week of 24 March.
By
Jill Adams
25 March 2025 | 2 min read
Keep sex as a biological variable: Don’t let NIH upheaval turn back the clock on scientific rigor
Even in the absence of any formal instruction to do so, we should continue to hold our ourselves and our neuroscience colleagues accountable for SABV practices.
Keep sex as a biological variable: Don’t let NIH upheaval turn back the clock on scientific rigor
Even in the absence of any formal instruction to do so, we should continue to hold our ourselves and our neuroscience colleagues accountable for SABV practices.
By
Rebecca Shansky
25 March 2025 | 7 min read
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
By
Ed Lein, Hongkui Zeng
24 March 2025 | 7 min read